Polyethylene Glycols for Wrist and Hand Injury of Unspecified Arm

Phase-Based Progress Estimates
Wrist and Hand Injury of Unspecified ArmPolyethylene Glycols - Drug
16 - 65
All Sexes
What conditions do you have?

Study Summary

This trial will test if PEG 3350 is safe and effective for repairing nerves.

Eligible Conditions
  • Wrist and Hand Injury of Unspecified Arm

Treatment Effectiveness

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: 12 months

12 months
To demonstrate more rapid and increased return of function by PEG-fusion compared to the best current nerve repair techniques

Trial Safety

Trial Design

1 Treatment Group

Nerve injury to palm and fingers
1 of 1

Experimental Treatment

10 Total Participants · 1 Treatment Group

Primary Treatment: Polyethylene Glycols · No Placebo Group · Phase 1

Nerve injury to palm and fingers
Experimental Group · 1 Intervention: Polyethylene Glycols · Intervention Types: Drug
First Studied
Drug Approval Stage
How many patients have taken this drug
Polyethylene Glycols
Completed Phase 4

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 months

Who is running the clinical trial?

WellSpan HealthLead Sponsor
23 Previous Clinical Trials
4,587 Total Patients Enrolled
Neuraptive Therapeutics Inc.Industry Sponsor
3 Previous Clinical Trials
76 Total Patients Enrolled
Richard C Trevino, MDPrincipal InvestigatorWellSpan York Hospital

Eligibility Criteria

Age 16 - 65 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are pregnant and breastfeeding.
You have a Class III nerve injury (Sunderland's 4th or 5th degree injury).
Nerve injuries that can be prepared using minimal or acceptable tension (according to surgeon discretion).
You have an injury that is beyond 24 hours.\n